Early-stage beta
· Errors & gaps may exist · Expanding: US · Nordics · EU
← All companies
/
Top lists
/
Abbott
Abbott
2016–2025 · Healthcare
2026-08-11
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
20 853
27 390
30 578
31 904
34 608
43 075
43 653
40 109
41 950
44 328
Operating profit (EBIT)
3 026
1 564
3 650
4 532
5 357
8 425
8 362
6 478
6 825
8 053
Net income attributable to shareholders
1 393
468
2 353
3 666
4 473
7 042
6 905
5 701
13 351
6 500
EBIT margin
14,5%
5,7%
11,9%
14,2%
15,5%
19,6%
19,2%
16,2%
16,3%
18,2%
Gross margin
56,7%
55,0%
58,5%
58,5%
56,7%
57,0%
56,2%
55,2%
55,4%
56,4%
Operating cash flow
3 203
5 570
6 300
6 136
7 901
10 533
9 581
7 261
8 558
9 566
Free cash flow
2 082
4 435
4 906
4 498
5 724
8 648
7 804
5 059
6 351
7 395
Cash
18 620
9 407
3 844
3 860
6 838
9 799
9 882
6 896
7 616
8 522
Interest-bearing debt
22 006
27 924
19 566
18 139
18 747
18 050
16 773
14 679
14 125
12 929
0
20 000
40 000
60 000
0,0%
5,0%
10,0%
15,0%
20,0%
25,0%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
20 853
27 390
30 578
31 904
34 608
43 075
43 653
40 109
41 950
44 328
3 026
1 564
3 650
4 532
5 357
8 425
8 362
6 478
6 825
8 053